Conditions: Neuroendocrine Tumors; MEN1 Mutation
Interventions: Biological: blood sample
Sponsors: Centre Hospitalier Universitaire Dijon
Recruiting
Feeds
32933 items (32933 unread) in 74 feeds
Acinar Cell Carcinoma
(534 unread)
Acinic Cell Carcinoma
(314 unread)
Adenoid Cystic Carcinoma
(566 unread)
Adrenal Gland Cancer
(2429 unread)
Ampulla Of Vater
(469 unread)
Anal Cancer
(2709 unread)
Angiosarcoma
(990 unread)
Appendix Cancer
(684 unread)
Bile Duct Cancer
(4355 unread)
Brain and CNS
(6120 unread)
Carcinoid
(887 unread)
Endocrine/Neuroendocrine
(5825 unread)
Gall Bladder Cancer
(1132 unread)
Hemangioendothelioma
(1176 unread)
Hepatoblastoma
(770 unread)
Pancreas
(563 unread)
Phyllodes
(384 unread)
PMP and Mucinous Tumors
(477 unread)
Rhabdomyosarcoma
(1118 unread)
Sarcoma
(1431 unread)
Trial - Insulinoma (8 unread)
-
Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation
Posted: May 27th, 2024, 11:00pm UTC
-
Evaluating ImmuNe Changes in the Evolution of Pre Type 1 Diabetes With Adult ONset
Posted: August 23rd, 2023, 11:00pm UTC
Conditions: Type 1 Diabetes; Type 1 Diabetes Mellitus Maturity Onset
Interventions: Genetic: High genetic risk for type 1 diabetes; Genetic: High gentic risk for Coeliac disease
Sponsors: Royal Devon and Exeter NHS Foundation Trust; University of Exeter
Completed -
DOTATOC PET/CT for Imaging NET Patients
Posted: July 11th, 2018, 11:00pm UTC
Conditions: Neuroendocrine Tumors; Insulinoma; Gastrinoma; Glucagonoma; Vipoma; Pheochromocytoma; Paraganglioma; Neuroblastoma; Ganglioneuroma; Medullary Carcinoma; Pituitary Adenoma; Medulloblastoma; Merkel Cell Carcinoma; Small-cell Lung Cancer; Meningioma; Carcinoid
Interventions: Diagnostic Test: 68Ga-DOTATOC PET/CT; Diagnostic Test: 18F-FDG PET/CT
Sponsors: British Columbia Cancer Agency
Recruiting -
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Posted: December 27th, 2013, 1:00am UTC
Conditions: Congenital Hyperinsulinism; Insulinoma
Interventions: Drug: Fluorodopa F 18
Sponsors: Cook Children's Health Care System
Recruiting -
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Posted: August 5th, 2013, 11:00pm UTC
Conditions: Congenital Hyperinsulinism (CHI); Beckwith-Wiedemann Syndrome; Insulinoma
Interventions: Drug: 18F-DOPA
Sponsors: Children's Hospital of Philadelphia
Available -
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Posted: February 2nd, 2012, 1:00am UTC
Conditions: Gastrinoma; Glucagonoma; Insulinoma; Pancreatic Polypeptide Tumor; Recurrent Islet Cell Carcinoma; Recurrent Pancreatic Cancer; Somatostatinoma; Stage III Pancreatic Cancer; Stage IV Pancreatic Cancer
Interventions: Drug: Capecitabine; Drug: Temozolomide; Biological: Bevacizumab
Sponsors: Shaheen Shagufta; National Cancer Institute (NCI)
Completed -
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Posted: April 10th, 2008, 11:00pm UTC
Conditions: Gastrinoma; Glucagonoma; Insulinoma; Metastatic Gastrointestinal Carcinoid Tumor; Metastatic Pheochromocytoma; Pancreatic Polypeptide Tumor; Recurrent Gastrointestinal Carcinoid Tumor; Recurrent Islet Cell Carcinoma; Recurrent Melanoma; Recurrent Neuroendocrine Carcinoma of the Skin; Recurrent Non-small Cell Lung Cancer; Recurrent Pheochromocytoma; Recurrent Renal Cell Cancer; Somatostatinoma; Stage III Neuroendocrine Carcinoma of the Skin; Stage IV Melanoma; Stage IV Non-small Cell Lung Cancer; Stage IV Renal Cell Cancer; Thyroid Gland Medullary Carcinoma; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: everolimus; Drug: vatalanib; Other: pharmacological study; Other: laboratory biomarker analysis; Procedure: dynamic contrast-enhanced magnetic resonance imaging; Procedure: ultrasound imaging
Sponsors: Mayo Clinic
Completed -
Diagnosing and Treating Low Blood Sugar Levels
Posted: November 4th, 1999, 1:00am UTC
Conditions: Hypoglycemia; Insulinoma
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting